Cover Image

An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis

Patient-reported outcomes are valuable for assessing new psoriasis therapies. This study investigated patient-reported outcomes in patients with moderate-to-severe plaque psoriasis treated with ixekizumab or ustekinumab, dosed according to their respective labels, for 52 weeks (IXORA-S-NCT02561806)....

Full description

Saved in:
Bibliographic Details
Main Authors: Lluís Puig (Author), Mark Lomaga (Author), Kristin Hollister (Author), Yves Dutronc (Author), Lovisa Berggren (Author), Peter C.M. van de Kerkhof (Author)
Format: Book
Published: Medical Journals Sweden, 2020-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items